πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 373 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11472782

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11466018

TGF-Ξ² inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11407736

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11377428

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11370764

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11370808

Pyrazole compounds and methods for making and using the compounds

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11370787

Pyrazole compounds, formulations thereof, and a method for using the compounds and/or form

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11370765

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11352360

TGF-beta inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11332451

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11299486

Benzazole compounds and methods for making and using the compounds

Rigel Pharmaceuticals, Inc. Β· Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11279686

Nrf2 activating compounds and uses thereof

Rigel Pharmaceuticals, Inc. Β· Granted Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11230554

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11220496

Compounds and method for treating autoimmune diseases

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11198689

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. Β· Granted Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11174251

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. Β· Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11174246

Direct AMPK activators

Rigel Pharmaceuticals, Inc. Β· Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11129819

Fumarate analogs and uses thereof

Rigel Pharmaceuticals, Inc. Β· Granted Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11110082

Tyrosine kinase inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11104737

ACVR2A-specific antibody and method of treatment of muscle atrophy

Rigel Pharmaceuticals, Inc. Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11059814

Kinase inhibitors and methods for making and using

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11021468

TGF-ß inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11007193

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. Β· Granted Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10975064

RIP1 inhibitory compounds and methods for making and using the same

Rigel Pharmaceuticals, Inc. Β· Granted Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted